Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07

    • 2'3'-cGAMP (sodium salt): Gold-Standard STING Agonist for...

    2026-03-20

    2'3'-cGAMP (sodium salt): Gold-Standard STING Agonist for Innate Immunity Research

    Executive Summary: 2'3'-cGAMP (sodium salt) is an endogenous cyclic dinucleotide and the most potent natural agonist of STING, with a binding affinity (Kd) of 3.79 nM under physiological buffer conditions (APExBIO product page). This reagent enables precise activation of the cGAS-STING pathway, leading to TBK1-IRF3-dependent type I interferon (IFN-β) induction, making it invaluable for immuno-oncology, antiviral, and inflammation studies (Shaji et al., 2024). It is water-soluble (≥7.56 mg/mL), chemically stable at -20°C, and exhibits superior efficacy compared to bacterial CDNs for triggering innate immune responses (Z-wehd-fmk.com). APExBIO supplies 2'3'-cGAMP (sodium salt) (SKU: B8362) as a validated, research-grade tool for dissecting STING-mediated signaling in preclinical models.

    Biological Rationale

    2'3'-cGAMP (sodium salt) is the endogenous mammalian second messenger synthesized by cGAS upon detection of cytosolic double-stranded DNA (dsDNA) (Shaji et al., 2024). Its unique 2'-5', 3'-5' phosphodiester linkage distinguishes it from bacterial cyclic dinucleotides. The cGAS-STING pathway is a primary sensor of DNA damage, viral infection, and cytosolic DNA, linking innate immune detection to type I interferon induction (Adarotene.com). This pathway is central to immunosurveillance, antiviral immunity, and the modulation of tumor microenvironments.

    • 2'3'-cGAMP is naturally produced in response to cytosolic dsDNA in mammalian cells.
    • The cGAS-STING axis is critical for bridging innate and adaptive immunity.
    • STING activation leads to type I IFN and pro-inflammatory cytokine release.
    • Dissecting cGAS-STING signaling is pivotal for understanding cancer immunotherapy, antiviral response, and autoimmunity.

    Mechanism of Action of 2'3'-cGAMP (sodium salt)

    Upon cytosolic dsDNA sensing, cGAS catalyzes the synthesis of 2'3'-cGAMP from ATP and GTP. 2'3'-cGAMP binds directly to the STING ER membrane protein with high affinity (Kd = 3.79 nM; buffer: PBS, 25°C) (APExBIO). This binding induces a conformational change in STING, enabling its translocation from the ER to the Golgi apparatus. STING then recruits and activates TBK1 kinase, leading to phosphorylation of IRF3, which translocates to the nucleus and drives type I interferon (IFN-β) gene expression (Shaji et al., 2024).

    • cGAS detects cytosolic dsDNA and synthesizes 2'3'-cGAMP.
    • 2'3'-cGAMP binds STING, triggering downstream TBK1 and IRF3 activation.
    • Activation results in robust type I IFN and chemokine production.
    • 2'3'-cGAMP has greater potency than bacterial CDNs due to its unique linkage and STING binding profile (Chir-258.com).

    Evidence & Benchmarks

    • 2'3'-cGAMP (sodium salt) is the highest-affinity natural STING agonist (Kd = 3.79 nM), outperforming c-di-GMP and c-di-AMP in mammalian STING binding assays (APExBIO).
    • Encapsulating 2'3'-cGAMP in lipid nanoparticles enhances cytosolic delivery and significantly reduces pancreatic tumor growth in a syngeneic mouse model (Shaji et al., 2024).
    • Intratumoral administration of 2'3'-cGAMP activates both innate and adaptive immunity, increasing tumor-infiltrating T cells and pro-inflammatory cytokines (Shaji et al., 2024).
    • 2'3'-cGAMP is water-soluble (≥7.56 mg/mL), stable at -20°C, and experimentally validated for cell-based and in vivo applications (APExBIO).
    • 2'3'-cGAMP enables benchmarking of STING pathway activators, outperforming bacterial CDNs in IFN-β induction assays (Z-wehd-fmk.com).

    For a detailed mechanistic comparison, the IFG-1.com review discusses the unique linkage and water solubility of 2'3'-cGAMP (sodium salt), while this article extends the discussion by focusing on translational efficacy and in vivo benchmarks.

    Applications, Limits & Misconceptions

    2'3'-cGAMP (sodium salt) is a critical reagent for:

    • Basic Immunology: Dissecting cGAS-STING signaling in cell lines and primary immune cells.
    • Immuno-oncology: Benchmarking tumor microenvironment modulation and immune checkpoint combination strategies (Shaji et al., 2024).
    • Antiviral Response: Modeling innate immunity to dsDNA viruses and retroviruses.
    • Autoimmune Disease Research: Exploring aberrant STING activation in lupus and ulcerative colitis models (23-cgamp.com).
    • Drug Screening: Serving as a reference STING agonist for evaluating new small molecules or biologics targeting the cGAS-STING pathway.

    Common Pitfalls or Misconceptions

    • Not a Diagnostic or Therapeutic Agent: 2'3'-cGAMP (sodium salt) is strictly for research use; it is not approved for clinical, diagnostic, or therapeutic applications (APExBIO).
    • Limited Cell Permeability: The molecule is membrane-impermeable; efficient cytosolic delivery requires transfection agents or nanoparticles (Shaji et al., 2024).
    • Not Effective on All STING Variants: Some human or murine STING alleles may respond differently; empirical validation is required for rare polymorphisms.
    • Solubility Constraints: Insoluble in ethanol and DMSO; must be dissolved in water at ≥7.56 mg/mL for experimental use (APExBIO).
    • Stability Issues: Store at -20°C; repeated freeze-thaw cycles can degrade activity.

    This article updates earlier discussions on adarotene.com by providing new in vivo benchmarks and delivery strategies for translational immunotherapy.

    Workflow Integration & Parameters

    • Solubility: Dissolve in water at ≥7.56 mg/mL. Do not use DMSO or ethanol as solvents.
    • Storage: Aliquot and store at -20°C. Avoid more than three freeze-thaw cycles.
    • Delivery: For in vitro use, deliver with cationic transfection reagents; for in vivo, use lipid nanoparticles or direct intratumoral injection (Shaji et al., 2024).
    • Concentration Ranges: Effective cellular activation observed at 0.5–10 μM in vitro; dose titration required for in vivo models.
    • Controls: Include vehicle and non-agonist cyclic dinucleotide controls for specificity.

    For practical in-lab integration, see the product datasheet and the IFG-1.com best practices guide (this article clarifies recent delivery advances).

    Conclusion & Outlook

    2'3'-cGAMP (sodium salt) from APExBIO (SKU: B8362) remains the gold-standard tool for activating and studying the cGAS-STING pathway. Its validated, high-affinity activity, water solubility, and robust induction of type I IFN responses make it indispensable for immunology, oncology, and antiviral research. Future directions include optimizing delivery technologies to overcome membrane impermeability and expanding its use in translational immunotherapy and biomarker discovery. For updated protocols and benchmarks, refer to the official product page and recent open access studies (Shaji et al., 2024).